Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
256.42 USD | +0.85% |
|
-0.64% | +12.13% |
15/07 | RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 | MT |
09/07 | Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing | MT |
Business description: ResMed, Inc.
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Number of employees: 9,980
Sales by Activity: ResMed, Inc.
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Sleep and Breathing Health | 260.24Cr | 282.32Cr | 317.73Cr | 372.5Cr | 410.12Cr |
Residential Care Software | 35Cr | 37Cr | 40Cr | 50Cr | 58Cr |
Geographical breakdown of sales: ResMed, Inc.
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
United States | 182.86Cr | 196.27Cr | 224.94Cr | 271.99Cr | 298.01Cr |
Rest of The World | 112.84Cr | 123.41Cr | 132.87Cr | 150.31Cr | 170.52Cr |
Executive Committee: ResMed, Inc.
Manager | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 52 | 01/03/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 58 | 01/01/2006 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
Carlos Nunez
CTO | Chief Tech/Sci/R&D Officer | - | 03/01/2017 |
Investor Relations Contact | - | 21/04/2025 |
Composition of the Board of Directors: ResMed, Inc.
Director | Title | Age | Since |
---|---|---|---|
Rich Sulpizio
BRD | Director/Board Member | 75 | 25/08/2005 |
Ron Taylor
BRD | Director/Board Member | 77 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 52 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 82 | 01/06/1989 |
Carol Burt
BRD | Director/Board Member | 67 | 01/11/2013 |
Karen Drexler
BRD | Director/Board Member | 65 | 17/11/2017 |
Harjit Gill
BRD | Director/Board Member | 60 | 15/11/2018 |
Jan De Witte
BRD | Director/Board Member | 60 | 16/05/2019 |
John Hernandez
BRD | Director/Board Member | 58 | 18/11/2021 |
Desney Tan
BRD | Director/Board Member | 49 | 18/11/2021 |
Holdings: ResMed, Inc.
Name | Equities | % | Valuation |
---|---|---|---|
NYXOAH SA 5.02% | 17,27,864 | 5.02% | 1,30,82,229 $ |
Company details: ResMed, Inc.

Group companies: ResMed, Inc.
Name | Category and Sector |
---|---|
ResMed Pty Ltd.
![]() ResMed Pty Ltd. Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed Pty Ltd. is an Australian company that designs, manufactures, and markets devices for the evaluation and treatment of sleep disorders. The company is based in Bella Vista, Australia. The company was founded in 1989, and Michael J. Farrell has been the CEO of the company since 2007. |
Medical Specialties
|
ResMed India Pvt Ltd.
![]() ResMed India Pvt Ltd. Medical/Nursing ServicesHealth Services Part of ResMed, Inc., ResMed India Pvt Ltd. is an Indian company that manufactures medical equipment. The company is based in Noida, India and was founded in 2007. |
Medical/Nursing Services
|
ResMed Corp.
![]() ResMed Corp. Medical SpecialtiesHealth Technology Part of ResMed, Inc., ResMed Corp. is a company that designs, manufactures, and markets devices for the evaluation and treatment of sleep disorders. The company is based in San Diego, MN. The company was founded in 1989 by Peter C. Farrell. Michael J. Farrell has been the CEO of the company since 2013. |
Medical Specialties
|
Other Advanced Medical Equipment & Technology
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.85% | -0.64% | +24.51% | +13.71% | 3.72TCr | ||
+0.69% | -1.88% | +21.10% | +144.72% | 18TCr | ||
+2.08% | -1.33% | -23.44% | -21.13% | 16TCr | ||
+1.41% | +0.76% | +35.19% | +178.70% | 15TCr | ||
+0.77% | -5.22% | -22.47% | -23.84% | 14TCr | ||
+1.04% | -2.63% | -13.30% | -3.98% | 6TCr | ||
+0.05% | -3.32% | -12.75% | -23.38% | 4.47TCr | ||
+1.18% | -0.67% | -22.71% | -31.50% | 3.61TCr | ||
+1.05% | -0.34% | -7.55% | - | 3.45TCr | ||
+2.58% | -6.29% | -12.84% | -2.08% | 3.22TCr | ||
Average | +0.78% | -2.26% | -3.43% | +25.69% | 8.77TCr | |
Weighted average by Cap. | +0.80% | -2.02% | +0.58% | +53.76% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
- Company ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition